Superior Vena Cava Flow in Children With Attention Deficit Hyperactivity Disorder

Muhammed Karabulut1, Kübra Yıldırım2

  • 1Department of Paediatric Cardiology, Clinical of Paediatric Health and Diseases, Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.

Psychiatry Investigation
|October 5, 2023
PubMed

Insights

This study found that children with Attention Deficit/Hyperactivity Disorder (ADHD) have higher superior vena cava (SVC) flow, an indicator of cerebral blood flow. Methylphenidate (MPH) treatment reduced this flow, suggesting its potential as a biomarker for ADHD diagnosis and treatment.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Cardiovascular Physiology

Background:

  • Attention Deficit/Hyperactivity Disorder (ADHD) is a common childhood neurobehavioral disorder with ongoing research into its pathophysiology.
  • Cerebral venous circulation in ADHD has not been extensively studied, nor has the impact of methylphenidate (MPH) on it.
  • Superior Vena Cava (SVC) flow, measured noninvasively via transthoracic echocardiography, serves as an indirect indicator of cerebral venous flow.

Purpose of the Study:

  • To investigate cerebral venous circulation in children with ADHD by measuring SVC flow.
  • To evaluate the effect of osmotic-release oral system (OROS)-MPH treatment on SVC flow in ADHD patients.

Main Methods:

  • Transthoracic echocardiography was used to measure SVC flow.
  • The study included 44 healthy children and 40 children diagnosed with ADHD.
  • SVC flows were recorded in healthy children and in ADHD patients before and after OROS-MPH treatment initiation.

Main Results:

  • ADHD patients exhibited significantly higher SVC flow compared to healthy controls.
  • OROS-MPH treatment led to a significant reduction in SVC flow among ADHD patients.
  • Patients with inadequate response to MPH treatment did not show a decrease in SVC flow.

Conclusions:

  • This study is the first to demonstrate an association between increased SVC flow and ADHD in children.
  • MPH treatment effectively reduced elevated SVC flow in ADHD patients.
  • Noninvasively measured SVC flow may serve as a valuable biomarker for ADHD diagnosis and treatment monitoring in future research.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
79
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
32
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
41